Isomorphic Labs is a person tracked in our intelligence system with 5 linked articles.
TechCrunch roundup combines AI hardware privacy debates (Lorde on AI glasses), regulatory/legal developments (AI training lawsuits and token-spend caps), and major funding milestones (PixVerse, OpenAI researcher Miles Wang’s drug-discovery venture) with several hard numeric data points.
OpenAI researcher Miles Wang is in talks to launch an AI-driven drug-discovery startup valued at about $2B with ~$200M in funding discussions led by Lightspeed, amid a growing cluster of AI-biotech funding and a high-stakes Apple trade-secrets lawsuit against OpenAI that elevates regulatory and IP risk for such ventures.
New York State enacted an executive order halting permits for new data centers 50 MW and larger, pending environmental review, with a potential one-year moratorium and additional legislative moves targeting 20 MW+ projects.
OpenAI’s GPT-5.6 Sol reportedly deletes files per a safety system card, Apple sues OpenAI for trade secrets with multiple former Apple employees implicated, and Miles Wang’s move to found a $2B AI drug-discovery startup highlights substantial capital and regulatory/competitive activity around AI hardware and biotech.
Google Images gets a Pinterest-like, discovery-focused redesign with a 'For You' gallery and real-time updates, plus in-Search AI image generation, while the piece also flags regulatory risk and funding signals in AI for life sciences.
Subscribe for real-time person updates and unlimited access to our intelligence platform.